REGULATIONS

federal civil and criminal false claims and civil monetary penalty laws, such as the federal
False Claims Act, which impose criminal and civil penalties and authorize civil
whistleblower or qui tam actions, against individuals or entities for, among other things:
knowingly presenting, or causing to be presented, to the federal government, claims for
payment that are false or fraudulent; making a false statement or record material to a false
or fraudulent claim or obligation to pay or transmit money or property to the federal
government; or knowingly concealing or knowingly and improperly avoiding or decreasing
an obligation to pay money to the federal government. In addition, the government may
assert that a claim including items and services resulting from a violation of the federal
Anti-Kickback Statute constitutes a false of fraudulent claim for purposes of the False
Claims Act;

the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which
prohibits knowingly and willfully executing, or attempting to execute, a scheme to defraud
any healthcare benefit program or obtain, by means of false or fraudulent pretenses,
representations, or promises, any of the money or property owned by, or under the custody
or control of, any healthcare benefit program, regardless of the payor (e.g., public or
private) and knowingly and willfully falsifying, concealing or covering up by any trick or
device a material fact or making any materially false statements in connection with the
delivery of, or payment for, healthcare benefits, items or services relating to healthcare
matters;

HIPAA, as amended by the Health Information Technology for Economic and Clinical
Health Act of 2009, and their
respective implementing regulations, which impose
requirements on certain covered healthcare providers, health plans and healthcare
clearinghouses as well as their respective business associates who perform services for
them that involve the use, or disclosure of, individually identifiable health information,
relating to the privacy, security and transmission of
individually identifiable health
information;

the federal false statements statute, which prohibits knowingly and willfully falsifying,
concealing or covering up a material fact or making any materially false statement in
connection with the delivery of or payment for healthcare benefits, items or services;

the federal transparency requirements under the ACA, including the provision commonly
referred to as the Physician Payments Sunshine Act, which require manufacturers of drugs,
devices, biologics and medical supplies for which payment is available under Medicare,
Medicaid or the Children’s Health Insurance Program to report annually to the U.S.
Department of Health and Human Services information related to payments or other
transfers of value made to physicians and teaching hospitals, as well as ownership and
investment interests held by physicians and their immediate family members; and

federal consumer protection and unfair competition laws, which broadly regulate
marketplace activities and activities that potentially harm consumers.

•

•

•

•

•

•

— 176 —

